- EHNA
drugbox
IUPAC_name = 3-(6-aminopurin-9-yl)nonan-2-ol hydrochloride
width = 180
CAS_number = 59262-86-1
ATC_prefix =
ATC_suffix =
PubChem = 359137
DrugBank =
C = 14 | H = 24 | Cl = 1 | N = 5 | O = 1
molecular_weight = 313.826 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category =
legal_AU =
legal_UK =
legal_US =
legal_status =
routes_of_administration =EHNA (erythro-9-(2-hydroxy-3-nonyl)adenine) is a
phosphodiesterase inhibitor that selectively inhibits phosphodiesterase type-2 (PDE2). [Podzuweit T, Nennstiel P and Muller A (1995) "Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine". "Cell Signal" 7:733-8. PMID 8519602] [Méry PF, Pavoine C, Pecker F and Fischmeister R (1995). "Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes". "Mol Pharmacol" 48:121-130 PMID 7623766]References
Wikimedia Foundation. 2010.